nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—CYP2C9—Rosuvastatin—atherosclerosis	0.108	0.267	CbGbCtD
Treprostinil—CYP2C9—Simvastatin—atherosclerosis	0.101	0.248	CbGbCtD
Treprostinil—CYP2C9—Pravastatin—atherosclerosis	0.0984	0.243	CbGbCtD
Treprostinil—CYP2C9—Lovastatin—atherosclerosis	0.0984	0.243	CbGbCtD
Treprostinil—P2RY12—artery—atherosclerosis	0.0201	0.228	CbGeAlD
Treprostinil—PTGIR—artery—atherosclerosis	0.0128	0.145	CbGeAlD
Treprostinil—PTGIR—endothelium—atherosclerosis	0.0108	0.123	CbGeAlD
Treprostinil—PTGIR—blood vessel—atherosclerosis	0.00997	0.113	CbGeAlD
Treprostinil—P2RY12—cardiovascular system—atherosclerosis	0.00697	0.0791	CbGeAlD
Treprostinil—PTGIR—connective tissue—atherosclerosis	0.00511	0.058	CbGeAlD
Treprostinil—PPARD—adipose tissue—atherosclerosis	0.00511	0.058	CbGeAlD
Treprostinil—PTGIR—cardiovascular system—atherosclerosis	0.00445	0.0505	CbGeAlD
Treprostinil—PTGIR—adipose tissue—atherosclerosis	0.00392	0.0445	CbGeAlD
Treprostinil—Haemoptysis—Niacin—atherosclerosis	0.00359	0.0133	CcSEcCtD
Treprostinil—PPARD—liver—atherosclerosis	0.00358	0.0407	CbGeAlD
Treprostinil—Viral infection—Ezetimibe—atherosclerosis	0.00336	0.0124	CcSEcCtD
Treprostinil—Neck pain—Ezetimibe—atherosclerosis	0.00307	0.0114	CcSEcCtD
Treprostinil—Viral infection—Pravastatin—atherosclerosis	0.0029	0.0107	CcSEcCtD
Treprostinil—Gout—Niacin—atherosclerosis	0.00285	0.0105	CcSEcCtD
Treprostinil—PTGIR—liver—atherosclerosis	0.00275	0.0312	CbGeAlD
Treprostinil—Cramps of lower extremities—Niacin—atherosclerosis	0.00244	0.00902	CcSEcCtD
Treprostinil—Influenza—Rosuvastatin—atherosclerosis	0.00229	0.00847	CcSEcCtD
Treprostinil—Pain in extremity—Lovastatin—atherosclerosis	0.00225	0.0083	CcSEcCtD
Treprostinil—Pain in extremity—Ezetimibe—atherosclerosis	0.0022	0.00814	CcSEcCtD
Treprostinil—Bronchitis—Rosuvastatin—atherosclerosis	0.0022	0.00814	CcSEcCtD
Treprostinil—Depression—Rosuvastatin—atherosclerosis	0.00204	0.00753	CcSEcCtD
Treprostinil—Urinary tract infection—Rosuvastatin—atherosclerosis	0.00199	0.00734	CcSEcCtD
Treprostinil—Haematuria—Rosuvastatin—atherosclerosis	0.00195	0.0072	CcSEcCtD
Treprostinil—Influenza—Lovastatin—atherosclerosis	0.00194	0.00718	CcSEcCtD
Treprostinil—Sinusitis—Rosuvastatin—atherosclerosis	0.00192	0.00708	CcSEcCtD
Treprostinil—Influenza—Ezetimibe—atherosclerosis	0.0019	0.00704	CcSEcCtD
Treprostinil—Abdominal discomfort—Lovastatin—atherosclerosis	0.00186	0.00688	CcSEcCtD
Treprostinil—Rhinitis—Rosuvastatin—atherosclerosis	0.00184	0.00679	CcSEcCtD
Treprostinil—Pharyngitis—Rosuvastatin—atherosclerosis	0.00182	0.00673	CcSEcCtD
Treprostinil—Bronchitis—Simvastatin—atherosclerosis	0.00175	0.00645	CcSEcCtD
Treprostinil—Abdominal discomfort—Simvastatin—atherosclerosis	0.00174	0.00643	CcSEcCtD
Treprostinil—Urinary tract infection—Lovastatin—atherosclerosis	0.00168	0.00622	CcSEcCtD
Treprostinil—Influenza—Niacin—atherosclerosis	0.00167	0.00616	CcSEcCtD
Treprostinil—Influenza—Pravastatin—atherosclerosis	0.00164	0.00607	CcSEcCtD
Treprostinil—Sinusitis—Lovastatin—atherosclerosis	0.00162	0.006	CcSEcCtD
Treprostinil—Depression—Simvastatin—atherosclerosis	0.00161	0.00597	CcSEcCtD
Treprostinil—Bronchitis—Niacin—atherosclerosis	0.0016	0.00593	CcSEcCtD
Treprostinil—Sinusitis—Ezetimibe—atherosclerosis	0.00159	0.00589	CcSEcCtD
Treprostinil—CYP2C9—cardiovascular system—atherosclerosis	0.00159	0.018	CbGeAlD
Treprostinil—Sinusitis—Simvastatin—atherosclerosis	0.00152	0.00561	CcSEcCtD
Treprostinil—Pharyngitis—Ezetimibe—atherosclerosis	0.00151	0.00559	CcSEcCtD
Treprostinil—Oedema peripheral—Ezetimibe—atherosclerosis	0.0015	0.00555	CcSEcCtD
Treprostinil—Depression—Pravastatin—atherosclerosis	0.00146	0.00539	CcSEcCtD
Treprostinil—Angioedema—Rosuvastatin—atherosclerosis	0.00146	0.00539	CcSEcCtD
Treprostinil—Flushing—Lovastatin—atherosclerosis	0.00144	0.00533	CcSEcCtD
Treprostinil—Urinary tract infection—Pravastatin—atherosclerosis	0.00142	0.00526	CcSEcCtD
Treprostinil—Flushing—Ezetimibe—atherosclerosis	0.00141	0.00523	CcSEcCtD
Treprostinil—Cough—Rosuvastatin—atherosclerosis	0.00139	0.00515	CcSEcCtD
Treprostinil—Sinusitis—Pravastatin—atherosclerosis	0.00137	0.00508	CcSEcCtD
Treprostinil—Myalgia—Rosuvastatin—atherosclerosis	0.00136	0.00502	CcSEcCtD
Treprostinil—Arthralgia—Rosuvastatin—atherosclerosis	0.00136	0.00502	CcSEcCtD
Treprostinil—Flushing—Simvastatin—atherosclerosis	0.00135	0.00499	CcSEcCtD
Treprostinil—Haemoglobin—Niacin—atherosclerosis	0.00134	0.00496	CcSEcCtD
Treprostinil—Rhinitis—Niacin—atherosclerosis	0.00134	0.00495	CcSEcCtD
Treprostinil—Haemorrhage—Niacin—atherosclerosis	0.00133	0.00493	CcSEcCtD
Treprostinil—Erythema—Ezetimibe—atherosclerosis	0.00133	0.0049	CcSEcCtD
Treprostinil—Rhinitis—Pravastatin—atherosclerosis	0.00132	0.00487	CcSEcCtD
Treprostinil—Oedema peripheral—Niacin—atherosclerosis	0.00131	0.00486	CcSEcCtD
Treprostinil—Back pain—Lovastatin—atherosclerosis	0.00131	0.00484	CcSEcCtD
Treprostinil—Pharyngitis—Pravastatin—atherosclerosis	0.0013	0.00482	CcSEcCtD
Treprostinil—Muscle spasms—Lovastatin—atherosclerosis	0.0013	0.00481	CcSEcCtD
Treprostinil—Infection—Rosuvastatin—atherosclerosis	0.00129	0.00478	CcSEcCtD
Treprostinil—Back pain—Ezetimibe—atherosclerosis	0.00128	0.00474	CcSEcCtD
Treprostinil—Muscle spasms—Ezetimibe—atherosclerosis	0.00128	0.00471	CcSEcCtD
Treprostinil—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00128	0.00471	CcSEcCtD
Treprostinil—Erythema—Simvastatin—atherosclerosis	0.00127	0.00468	CcSEcCtD
Treprostinil—Ill-defined disorder—Lovastatin—atherosclerosis	0.00125	0.00464	CcSEcCtD
Treprostinil—Flushing—Niacin—atherosclerosis	0.00124	0.00458	CcSEcCtD
Treprostinil—Angioedema—Lovastatin—atherosclerosis	0.00124	0.00457	CcSEcCtD
Treprostinil—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00123	0.00455	CcSEcCtD
Treprostinil—Anaemia—Ezetimibe—atherosclerosis	0.00123	0.00453	CcSEcCtD
Treprostinil—Malaise—Lovastatin—atherosclerosis	0.00122	0.00451	CcSEcCtD
Treprostinil—Flushing—Pravastatin—atherosclerosis	0.00122	0.00451	CcSEcCtD
Treprostinil—Muscle spasms—Simvastatin—atherosclerosis	0.00122	0.0045	CcSEcCtD
Treprostinil—Angioedema—Ezetimibe—atherosclerosis	0.00121	0.00448	CcSEcCtD
Treprostinil—Malaise—Ezetimibe—atherosclerosis	0.0012	0.00442	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00119	0.00439	CcSEcCtD
Treprostinil—Insomnia—Rosuvastatin—atherosclerosis	0.00118	0.00435	CcSEcCtD
Treprostinil—Ill-defined disorder—Simvastatin—atherosclerosis	0.00117	0.00434	CcSEcCtD
Treprostinil—Palpitations—Ezetimibe—atherosclerosis	0.00117	0.00433	CcSEcCtD
Treprostinil—Paraesthesia—Rosuvastatin—atherosclerosis	0.00117	0.00432	CcSEcCtD
Treprostinil—Anaemia—Simvastatin—atherosclerosis	0.00117	0.00432	CcSEcCtD
Treprostinil—Erythema—Niacin—atherosclerosis	0.00116	0.00429	CcSEcCtD
Treprostinil—Cough—Ezetimibe—atherosclerosis	0.00116	0.00428	CcSEcCtD
Treprostinil—Angioedema—Simvastatin—atherosclerosis	0.00116	0.00427	CcSEcCtD
Treprostinil—Myalgia—Lovastatin—atherosclerosis	0.00115	0.00426	CcSEcCtD
Treprostinil—Chest pain—Lovastatin—atherosclerosis	0.00115	0.00426	CcSEcCtD
Treprostinil—Arthralgia—Lovastatin—atherosclerosis	0.00115	0.00426	CcSEcCtD
Treprostinil—Anxiety—Lovastatin—atherosclerosis	0.00115	0.00424	CcSEcCtD
Treprostinil—Dyspepsia—Rosuvastatin—atherosclerosis	0.00115	0.00424	CcSEcCtD
Treprostinil—Malaise—Simvastatin—atherosclerosis	0.00114	0.00422	CcSEcCtD
Treprostinil—Tension—Niacin—atherosclerosis	0.00114	0.00421	CcSEcCtD
Treprostinil—Discomfort—Lovastatin—atherosclerosis	0.00114	0.00421	CcSEcCtD
Treprostinil—Myalgia—Ezetimibe—atherosclerosis	0.00113	0.00417	CcSEcCtD
Treprostinil—Arthralgia—Ezetimibe—atherosclerosis	0.00113	0.00417	CcSEcCtD
Treprostinil—Chest pain—Ezetimibe—atherosclerosis	0.00113	0.00417	CcSEcCtD
Treprostinil—Nervousness—Niacin—atherosclerosis	0.00113	0.00417	CcSEcCtD
Treprostinil—Tension—Pravastatin—atherosclerosis	0.00112	0.00415	CcSEcCtD
Treprostinil—Muscle spasms—Niacin—atherosclerosis	0.00112	0.00413	CcSEcCtD
Treprostinil—Discomfort—Ezetimibe—atherosclerosis	0.00112	0.00412	CcSEcCtD
Treprostinil—Pain—Rosuvastatin—atherosclerosis	0.00111	0.00412	CcSEcCtD
Treprostinil—Nervousness—Pravastatin—atherosclerosis	0.00111	0.00411	CcSEcCtD
Treprostinil—Muscle spasms—Pravastatin—atherosclerosis	0.0011	0.00406	CcSEcCtD
Treprostinil—Infection—Lovastatin—atherosclerosis	0.0011	0.00405	CcSEcCtD
Treprostinil—Thrombocytopenia—Lovastatin—atherosclerosis	0.00108	0.004	CcSEcCtD
Treprostinil—Arthralgia—Simvastatin—atherosclerosis	0.00108	0.00398	CcSEcCtD
Treprostinil—Chest pain—Simvastatin—atherosclerosis	0.00108	0.00398	CcSEcCtD
Treprostinil—Myalgia—Simvastatin—atherosclerosis	0.00108	0.00398	CcSEcCtD
Treprostinil—Infection—Ezetimibe—atherosclerosis	0.00108	0.00398	CcSEcCtD
Treprostinil—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00107	0.00397	CcSEcCtD
Treprostinil—Anxiety—Simvastatin—atherosclerosis	0.00107	0.00397	CcSEcCtD
Treprostinil—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00107	0.00394	CcSEcCtD
Treprostinil—Discomfort—Simvastatin—atherosclerosis	0.00106	0.00393	CcSEcCtD
Treprostinil—Angioedema—Niacin—atherosclerosis	0.00106	0.00392	CcSEcCtD
Treprostinil—Ill-defined disorder—Pravastatin—atherosclerosis	0.00106	0.00392	CcSEcCtD
Treprostinil—Thrombocytopenia—Ezetimibe—atherosclerosis	0.00106	0.00392	CcSEcCtD
Treprostinil—Anaemia—Pravastatin—atherosclerosis	0.00106	0.00391	CcSEcCtD
Treprostinil—Anorexia—Lovastatin—atherosclerosis	0.00105	0.00389	CcSEcCtD
Treprostinil—Angioedema—Pravastatin—atherosclerosis	0.00105	0.00386	CcSEcCtD
Treprostinil—Syncope—Niacin—atherosclerosis	0.00104	0.00385	CcSEcCtD
Treprostinil—Oedema—Simvastatin—atherosclerosis	0.00103	0.00382	CcSEcCtD
Treprostinil—Malaise—Pravastatin—atherosclerosis	0.00103	0.00381	CcSEcCtD
Treprostinil—Abdominal pain—Rosuvastatin—atherosclerosis	0.00103	0.00381	CcSEcCtD
Treprostinil—Palpitations—Niacin—atherosclerosis	0.00103	0.00379	CcSEcCtD
Treprostinil—Infection—Simvastatin—atherosclerosis	0.00103	0.00379	CcSEcCtD
Treprostinil—Loss of consciousness—Niacin—atherosclerosis	0.00102	0.00377	CcSEcCtD
Treprostinil—Cough—Niacin—atherosclerosis	0.00101	0.00375	CcSEcCtD
Treprostinil—Thrombocytopenia—Simvastatin—atherosclerosis	0.00101	0.00374	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00101	0.00372	CcSEcCtD
Treprostinil—Insomnia—Lovastatin—atherosclerosis	0.000998	0.00369	CcSEcCtD
Treprostinil—Cough—Pravastatin—atherosclerosis	0.000998	0.00369	CcSEcCtD
Treprostinil—Paraesthesia—Lovastatin—atherosclerosis	0.000991	0.00366	CcSEcCtD
Treprostinil—Arthralgia—Niacin—atherosclerosis	0.000989	0.00366	CcSEcCtD
Treprostinil—Myalgia—Niacin—atherosclerosis	0.000989	0.00366	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000986	0.00365	CcSEcCtD
Treprostinil—Anorexia—Simvastatin—atherosclerosis	0.000984	0.00364	CcSEcCtD
Treprostinil—Dyspnoea—Lovastatin—atherosclerosis	0.000984	0.00364	CcSEcCtD
Treprostinil—CYP2C9—liver—atherosclerosis	0.000983	0.0112	CbGeAlD
Treprostinil—Insomnia—Ezetimibe—atherosclerosis	0.000979	0.00362	CcSEcCtD
Treprostinil—Arthralgia—Pravastatin—atherosclerosis	0.000974	0.0036	CcSEcCtD
Treprostinil—Chest pain—Pravastatin—atherosclerosis	0.000974	0.0036	CcSEcCtD
Treprostinil—Myalgia—Pravastatin—atherosclerosis	0.000974	0.0036	CcSEcCtD
Treprostinil—Paraesthesia—Ezetimibe—atherosclerosis	0.000972	0.00359	CcSEcCtD
Treprostinil—Dyspepsia—Lovastatin—atherosclerosis	0.000972	0.00359	CcSEcCtD
Treprostinil—Anxiety—Pravastatin—atherosclerosis	0.00097	0.00359	CcSEcCtD
Treprostinil—Dyspnoea—Ezetimibe—atherosclerosis	0.000965	0.00357	CcSEcCtD
Treprostinil—Discomfort—Pravastatin—atherosclerosis	0.000962	0.00356	CcSEcCtD
Treprostinil—Decreased appetite—Lovastatin—atherosclerosis	0.00096	0.00355	CcSEcCtD
Treprostinil—Dyspepsia—Ezetimibe—atherosclerosis	0.000953	0.00352	CcSEcCtD
Treprostinil—Fatigue—Lovastatin—atherosclerosis	0.000952	0.00352	CcSEcCtD
Treprostinil—Oedema—Niacin—atherosclerosis	0.000948	0.0035	CcSEcCtD
Treprostinil—Pain—Lovastatin—atherosclerosis	0.000944	0.00349	CcSEcCtD
Treprostinil—Decreased appetite—Ezetimibe—atherosclerosis	0.000941	0.00348	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000941	0.00348	CcSEcCtD
Treprostinil—Asthenia—Rosuvastatin—atherosclerosis	0.000935	0.00345	CcSEcCtD
Treprostinil—Insomnia—Simvastatin—atherosclerosis	0.000934	0.00345	CcSEcCtD
Treprostinil—Oedema—Pravastatin—atherosclerosis	0.000933	0.00345	CcSEcCtD
Treprostinil—Fatigue—Ezetimibe—atherosclerosis	0.000933	0.00345	CcSEcCtD
Treprostinil—Shock—Niacin—atherosclerosis	0.000933	0.00345	CcSEcCtD
Treprostinil—Infection—Pravastatin—atherosclerosis	0.000927	0.00343	CcSEcCtD
Treprostinil—Paraesthesia—Simvastatin—atherosclerosis	0.000927	0.00343	CcSEcCtD
Treprostinil—Pain—Ezetimibe—atherosclerosis	0.000926	0.00342	CcSEcCtD
Treprostinil—Tachycardia—Niacin—atherosclerosis	0.000925	0.00342	CcSEcCtD
Treprostinil—Pruritus—Rosuvastatin—atherosclerosis	0.000922	0.00341	CcSEcCtD
Treprostinil—Dyspnoea—Simvastatin—atherosclerosis	0.000921	0.0034	CcSEcCtD
Treprostinil—Thrombocytopenia—Pravastatin—atherosclerosis	0.000914	0.00338	CcSEcCtD
Treprostinil—Feeling abnormal—Lovastatin—atherosclerosis	0.00091	0.00336	CcSEcCtD
Treprostinil—Dyspepsia—Simvastatin—atherosclerosis	0.000909	0.00336	CcSEcCtD
Treprostinil—Anorexia—Niacin—atherosclerosis	0.000904	0.00334	CcSEcCtD
Treprostinil—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000903	0.00334	CcSEcCtD
Treprostinil—Decreased appetite—Simvastatin—atherosclerosis	0.000898	0.00332	CcSEcCtD
Treprostinil—Feeling abnormal—Ezetimibe—atherosclerosis	0.000892	0.0033	CcSEcCtD
Treprostinil—Diarrhoea—Rosuvastatin—atherosclerosis	0.000891	0.00329	CcSEcCtD
Treprostinil—Fatigue—Simvastatin—atherosclerosis	0.00089	0.00329	CcSEcCtD
Treprostinil—Anorexia—Pravastatin—atherosclerosis	0.00089	0.00329	CcSEcCtD
Treprostinil—Hypotension—Niacin—atherosclerosis	0.000886	0.00327	CcSEcCtD
Treprostinil—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000885	0.00327	CcSEcCtD
Treprostinil—Pain—Simvastatin—atherosclerosis	0.000883	0.00326	CcSEcCtD
Treprostinil—Body temperature increased—Lovastatin—atherosclerosis	0.000873	0.00323	CcSEcCtD
Treprostinil—Abdominal pain—Lovastatin—atherosclerosis	0.000873	0.00323	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000864	0.00319	CcSEcCtD
Treprostinil—Dizziness—Rosuvastatin—atherosclerosis	0.000861	0.00318	CcSEcCtD
Treprostinil—Insomnia—Niacin—atherosclerosis	0.000857	0.00317	CcSEcCtD
Treprostinil—Body temperature increased—Ezetimibe—atherosclerosis	0.000856	0.00316	CcSEcCtD
Treprostinil—Abdominal pain—Ezetimibe—atherosclerosis	0.000856	0.00316	CcSEcCtD
Treprostinil—Paraesthesia—Niacin—atherosclerosis	0.000851	0.00315	CcSEcCtD
Treprostinil—Feeling abnormal—Simvastatin—atherosclerosis	0.000851	0.00315	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00085	0.00314	CcSEcCtD
Treprostinil—Dyspnoea—Niacin—atherosclerosis	0.000845	0.00312	CcSEcCtD
Treprostinil—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000844	0.00312	CcSEcCtD
Treprostinil—Insomnia—Pravastatin—atherosclerosis	0.000844	0.00312	CcSEcCtD
Treprostinil—Paraesthesia—Pravastatin—atherosclerosis	0.000838	0.0031	CcSEcCtD
Treprostinil—Dyspepsia—Niacin—atherosclerosis	0.000835	0.00308	CcSEcCtD
Treprostinil—Dyspnoea—Pravastatin—atherosclerosis	0.000832	0.00308	CcSEcCtD
Treprostinil—Decreased appetite—Niacin—atherosclerosis	0.000824	0.00305	CcSEcCtD
Treprostinil—Dyspepsia—Pravastatin—atherosclerosis	0.000822	0.00304	CcSEcCtD
Treprostinil—Rash—Rosuvastatin—atherosclerosis	0.000821	0.00304	CcSEcCtD
Treprostinil—Dermatitis—Rosuvastatin—atherosclerosis	0.000821	0.00303	CcSEcCtD
Treprostinil—Body temperature increased—Simvastatin—atherosclerosis	0.000816	0.00302	CcSEcCtD
Treprostinil—Abdominal pain—Simvastatin—atherosclerosis	0.000816	0.00302	CcSEcCtD
Treprostinil—Headache—Rosuvastatin—atherosclerosis	0.000816	0.00302	CcSEcCtD
Treprostinil—Decreased appetite—Pravastatin—atherosclerosis	0.000811	0.003	CcSEcCtD
Treprostinil—Pain—Niacin—atherosclerosis	0.000811	0.003	CcSEcCtD
Treprostinil—Fatigue—Pravastatin—atherosclerosis	0.000805	0.00297	CcSEcCtD
Treprostinil—Pain—Pravastatin—atherosclerosis	0.000798	0.00295	CcSEcCtD
Treprostinil—Asthenia—Lovastatin—atherosclerosis	0.000792	0.00293	CcSEcCtD
Treprostinil—Pruritus—Lovastatin—atherosclerosis	0.000781	0.00289	CcSEcCtD
Treprostinil—Asthenia—Ezetimibe—atherosclerosis	0.000777	0.00287	CcSEcCtD
Treprostinil—Gastrointestinal pain—Niacin—atherosclerosis	0.000775	0.00287	CcSEcCtD
Treprostinil—Nausea—Rosuvastatin—atherosclerosis	0.000774	0.00286	CcSEcCtD
Treprostinil—Feeling abnormal—Pravastatin—atherosclerosis	0.000769	0.00284	CcSEcCtD
Treprostinil—Pruritus—Ezetimibe—atherosclerosis	0.000766	0.00283	CcSEcCtD
Treprostinil—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000763	0.00282	CcSEcCtD
Treprostinil—Diarrhoea—Lovastatin—atherosclerosis	0.000755	0.00279	CcSEcCtD
Treprostinil—Abdominal pain—Niacin—atherosclerosis	0.000749	0.00277	CcSEcCtD
Treprostinil—Body temperature increased—Niacin—atherosclerosis	0.000749	0.00277	CcSEcCtD
Treprostinil—Asthenia—Simvastatin—atherosclerosis	0.000741	0.00274	CcSEcCtD
Treprostinil—Diarrhoea—Ezetimibe—atherosclerosis	0.000741	0.00274	CcSEcCtD
Treprostinil—Body temperature increased—Pravastatin—atherosclerosis	0.000738	0.00273	CcSEcCtD
Treprostinil—Abdominal pain—Pravastatin—atherosclerosis	0.000738	0.00273	CcSEcCtD
Treprostinil—Pruritus—Simvastatin—atherosclerosis	0.000731	0.0027	CcSEcCtD
Treprostinil—Dizziness—Lovastatin—atherosclerosis	0.00073	0.0027	CcSEcCtD
Treprostinil—Dizziness—Ezetimibe—atherosclerosis	0.000716	0.00265	CcSEcCtD
Treprostinil—Diarrhoea—Simvastatin—atherosclerosis	0.000706	0.00261	CcSEcCtD
Treprostinil—Vomiting—Lovastatin—atherosclerosis	0.000702	0.00259	CcSEcCtD
Treprostinil—Rash—Lovastatin—atherosclerosis	0.000696	0.00257	CcSEcCtD
Treprostinil—Dermatitis—Lovastatin—atherosclerosis	0.000695	0.00257	CcSEcCtD
Treprostinil—Headache—Lovastatin—atherosclerosis	0.000692	0.00256	CcSEcCtD
Treprostinil—Vomiting—Ezetimibe—atherosclerosis	0.000688	0.00254	CcSEcCtD
Treprostinil—Dizziness—Simvastatin—atherosclerosis	0.000683	0.00252	CcSEcCtD
Treprostinil—Rash—Ezetimibe—atherosclerosis	0.000683	0.00252	CcSEcCtD
Treprostinil—Dermatitis—Ezetimibe—atherosclerosis	0.000682	0.00252	CcSEcCtD
Treprostinil—Asthenia—Niacin—atherosclerosis	0.00068	0.00251	CcSEcCtD
Treprostinil—Headache—Ezetimibe—atherosclerosis	0.000678	0.00251	CcSEcCtD
Treprostinil—Pruritus—Niacin—atherosclerosis	0.000671	0.00248	CcSEcCtD
Treprostinil—Asthenia—Pravastatin—atherosclerosis	0.00067	0.00248	CcSEcCtD
Treprostinil—Pruritus—Pravastatin—atherosclerosis	0.00066	0.00244	CcSEcCtD
Treprostinil—Vomiting—Simvastatin—atherosclerosis	0.000656	0.00243	CcSEcCtD
Treprostinil—Nausea—Lovastatin—atherosclerosis	0.000656	0.00242	CcSEcCtD
Treprostinil—Rash—Simvastatin—atherosclerosis	0.000651	0.00241	CcSEcCtD
Treprostinil—Dermatitis—Simvastatin—atherosclerosis	0.00065	0.0024	CcSEcCtD
Treprostinil—Diarrhoea—Niacin—atherosclerosis	0.000649	0.0024	CcSEcCtD
Treprostinil—Headache—Simvastatin—atherosclerosis	0.000647	0.00239	CcSEcCtD
Treprostinil—Nausea—Ezetimibe—atherosclerosis	0.000643	0.00238	CcSEcCtD
Treprostinil—Diarrhoea—Pravastatin—atherosclerosis	0.000639	0.00236	CcSEcCtD
Treprostinil—Dizziness—Niacin—atherosclerosis	0.000627	0.00232	CcSEcCtD
Treprostinil—Dizziness—Pravastatin—atherosclerosis	0.000617	0.00228	CcSEcCtD
Treprostinil—Nausea—Simvastatin—atherosclerosis	0.000613	0.00227	CcSEcCtD
Treprostinil—Vomiting—Niacin—atherosclerosis	0.000603	0.00223	CcSEcCtD
Treprostinil—Rash—Niacin—atherosclerosis	0.000598	0.00221	CcSEcCtD
Treprostinil—Dermatitis—Niacin—atherosclerosis	0.000597	0.00221	CcSEcCtD
Treprostinil—Headache—Niacin—atherosclerosis	0.000594	0.0022	CcSEcCtD
Treprostinil—Vomiting—Pravastatin—atherosclerosis	0.000594	0.00219	CcSEcCtD
Treprostinil—Rash—Pravastatin—atherosclerosis	0.000589	0.00218	CcSEcCtD
Treprostinil—Dermatitis—Pravastatin—atherosclerosis	0.000588	0.00217	CcSEcCtD
Treprostinil—Headache—Pravastatin—atherosclerosis	0.000585	0.00216	CcSEcCtD
Treprostinil—Nausea—Niacin—atherosclerosis	0.000563	0.00208	CcSEcCtD
Treprostinil—Nausea—Pravastatin—atherosclerosis	0.000554	0.00205	CcSEcCtD
Treprostinil—PTGIR—Hemostasis—NOS3—atherosclerosis	0.000133	0.000563	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CNR2—atherosclerosis	0.000132	0.000559	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—CXCL8—atherosclerosis	0.000132	0.000558	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MMP3—atherosclerosis	0.000131	0.000557	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PRKCG—atherosclerosis	0.00013	0.000551	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—AKT1—atherosclerosis	0.000129	0.000545	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SIRT1—atherosclerosis	0.000129	0.000545	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PRKCG—atherosclerosis	0.000128	0.000543	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VWF—atherosclerosis	0.000128	0.000541	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOC3—atherosclerosis	0.000127	0.000538	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LDLR—atherosclerosis	0.000126	0.000534	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—EDN1—atherosclerosis	0.000125	0.00053	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AGT—atherosclerosis	0.000124	0.000527	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL5—atherosclerosis	0.000124	0.000526	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL3—atherosclerosis	0.000123	0.000522	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000121	0.000515	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ABCA1—atherosclerosis	0.00012	0.000508	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PRKCG—atherosclerosis	0.000118	0.0005	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NCF1—atherosclerosis	0.000118	0.0005	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VWF—atherosclerosis	0.000117	0.000498	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOC3—atherosclerosis	0.000117	0.000495	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LDLR—atherosclerosis	0.000116	0.000492	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000116	0.00049	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—F2—atherosclerosis	0.000115	0.000487	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AGT—atherosclerosis	0.000114	0.000485	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL3—atherosclerosis	0.000113	0.00048	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AGT—atherosclerosis	0.000113	0.000478	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTM1—atherosclerosis	0.000113	0.000478	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCR2—atherosclerosis	0.000111	0.000472	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDNRA—atherosclerosis	0.000111	0.000472	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTM1—atherosclerosis	0.000111	0.000471	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CYBA—atherosclerosis	0.000111	0.00047	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PIK3CG—atherosclerosis	0.00011	0.000466	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000109	0.000461	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000109	0.000461	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLAT—atherosclerosis	0.000108	0.00046	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NCF1—atherosclerosis	0.000108	0.00046	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PARP1—atherosclerosis	0.000108	0.00046	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GHRL—atherosclerosis	0.000108	0.00046	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARA—atherosclerosis	0.000107	0.000453	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000107	0.000453	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—F2—atherosclerosis	0.000106	0.000448	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000105	0.000445	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—F2—atherosclerosis	0.000104	0.000442	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—atherosclerosis	0.000104	0.000441	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AGT—atherosclerosis	0.000104	0.00044	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—HMOX1—atherosclerosis	0.000103	0.000436	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCR2—atherosclerosis	0.000102	0.000434	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDNRA—atherosclerosis	0.000102	0.000434	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CYBA—atherosclerosis	0.000102	0.000433	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PIK3CG—atherosclerosis	0.000101	0.000428	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLAT—atherosclerosis	9.98e-05	0.000423	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PARP1—atherosclerosis	9.98e-05	0.000423	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GHRL—atherosclerosis	9.98e-05	0.000423	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PIK3CG—atherosclerosis	9.97e-05	0.000423	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOB—atherosclerosis	9.85e-05	0.000418	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—MAPK3—atherosclerosis	9.82e-05	0.000417	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	9.68e-05	0.000411	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ESR1—atherosclerosis	9.68e-05	0.000411	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—F2—atherosclerosis	9.58e-05	0.000407	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTM1—atherosclerosis	9.58e-05	0.000406	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—atherosclerosis	9.56e-05	0.000405	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TGFB1—atherosclerosis	9.53e-05	0.000404	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—KNG1—atherosclerosis	9.52e-05	0.000404	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGTR1—atherosclerosis	9.46e-05	0.000401	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—LPL—atherosclerosis	9.4e-05	0.000399	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CCL2—atherosclerosis	9.28e-05	0.000394	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLG—atherosclerosis	9.22e-05	0.000391	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	9.18e-05	0.00039	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	9.18e-05	0.00039	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	9.18e-05	0.00039	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	9.18e-05	0.00039	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GPX1—atherosclerosis	9.17e-05	0.000389	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PIK3CG—atherosclerosis	9.17e-05	0.000389	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	9.07e-05	0.000385	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—MAPK3—atherosclerosis	9.04e-05	0.000384	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CD36—atherosclerosis	8.93e-05	0.000379	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—PPARG—atherosclerosis	8.83e-05	0.000375	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TGFB1—atherosclerosis	8.77e-05	0.000372	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—KNG1—atherosclerosis	8.76e-05	0.000372	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	8.76e-05	0.000372	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SOCS3—atherosclerosis	8.73e-05	0.00037	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGTR1—atherosclerosis	8.71e-05	0.000369	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CCL2—atherosclerosis	8.54e-05	0.000362	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLG—atherosclerosis	8.48e-05	0.00036	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—MTHFR—atherosclerosis	8.47e-05	0.000359	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP3—atherosclerosis	8.43e-05	0.000358	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	8.4e-05	0.000356	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF2—atherosclerosis	8.39e-05	0.000356	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARA—atherosclerosis	8.31e-05	0.000352	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOB—atherosclerosis	8.15e-05	0.000346	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	8.08e-05	0.000343	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—CXCL8—atherosclerosis	8.08e-05	0.000343	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AGT—atherosclerosis	8.04e-05	0.000341	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SOCS3—atherosclerosis	8.03e-05	0.000341	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—EDN1—atherosclerosis	8.02e-05	0.00034	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	7.99e-05	0.000339	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL5—atherosclerosis	7.96e-05	0.000338	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SERPINE1—atherosclerosis	7.95e-05	0.000338	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—atherosclerosis	7.88e-05	0.000334	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CAV1—atherosclerosis	7.81e-05	0.000331	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	7.81e-05	0.000331	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOA1—atherosclerosis	7.79e-05	0.000331	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LPL—atherosclerosis	7.78e-05	0.00033	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP3—atherosclerosis	7.76e-05	0.000329	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF2—atherosclerosis	7.73e-05	0.000328	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PRKCG—atherosclerosis	7.57e-05	0.000321	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLTP—atherosclerosis	7.51e-05	0.000319	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOB—atherosclerosis	7.5e-05	0.000318	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—CXCL8—atherosclerosis	7.44e-05	0.000316	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—EDN1—atherosclerosis	7.38e-05	0.000313	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SPP1—atherosclerosis	7.37e-05	0.000313	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—CXCL8—atherosclerosis	7.34e-05	0.000311	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL5—atherosclerosis	7.32e-05	0.000311	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LPL—atherosclerosis	7.16e-05	0.000304	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PIK3CG—atherosclerosis	7.11e-05	0.000302	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PRKCG—atherosclerosis	6.96e-05	0.000295	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	6.96e-05	0.000295	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	6.91e-05	0.000293	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	6.87e-05	0.000292	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PPARG—atherosclerosis	6.87e-05	0.000291	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PDGFB—atherosclerosis	6.82e-05	0.000289	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SPP1—atherosclerosis	6.78e-05	0.000288	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—CXCL8—atherosclerosis	6.75e-05	0.000287	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—INS—atherosclerosis	6.73e-05	0.000286	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	6.71e-05	0.000285	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AGT—atherosclerosis	6.66e-05	0.000282	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—AKT1—atherosclerosis	6.63e-05	0.000281	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—LEP—atherosclerosis	6.52e-05	0.000277	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—atherosclerosis	6.52e-05	0.000277	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG8—atherosclerosis	6.51e-05	0.000276	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LTA4H—atherosclerosis	6.51e-05	0.000276	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CAV1—atherosclerosis	6.46e-05	0.000274	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOA1—atherosclerosis	6.45e-05	0.000274	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	6.43e-05	0.000273	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PDGFB—atherosclerosis	6.28e-05	0.000266	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ESR1—atherosclerosis	6.23e-05	0.000264	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—ALB—atherosclerosis	6.17e-05	0.000262	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—F2—atherosclerosis	6.15e-05	0.000261	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AGT—atherosclerosis	6.13e-05	0.00026	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—AKT1—atherosclerosis	6.1e-05	0.000259	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	6.07e-05	0.000258	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—LEP—atherosclerosis	6e-05	0.000255	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—atherosclerosis	6e-05	0.000255	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CAV1—atherosclerosis	5.95e-05	0.000252	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOA1—atherosclerosis	5.93e-05	0.000252	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—NOS3—atherosclerosis	5.91e-05	0.000251	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PIK3CG—atherosclerosis	5.89e-05	0.00025	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ESR1—atherosclerosis	5.73e-05	0.000243	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—F2—atherosclerosis	5.66e-05	0.00024	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MAPK3—atherosclerosis	5.64e-05	0.000239	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—INS—atherosclerosis	5.57e-05	0.000236	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CCL2—atherosclerosis	5.48e-05	0.000233	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PIK3CG—atherosclerosis	5.42e-05	0.00023	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	5.41e-05	0.00023	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—atherosclerosis	5.4e-05	0.000229	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—atherosclerosis	5.39e-05	0.000229	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MAPK3—atherosclerosis	5.19e-05	0.00022	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—MAPK3—atherosclerosis	5.18e-05	0.00022	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG1—atherosclerosis	5.15e-05	0.000218	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—INS—atherosclerosis	5.13e-05	0.000218	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SERPINE1—atherosclerosis	5.12e-05	0.000217	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CCL2—atherosclerosis	5.05e-05	0.000214	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—atherosclerosis	4.96e-05	0.00021	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NOS3—atherosclerosis	4.89e-05	0.000207	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LCAT—atherosclerosis	4.84e-05	0.000205	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FABP4—atherosclerosis	4.84e-05	0.000205	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA4—atherosclerosis	4.75e-05	0.000202	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SERPINE1—atherosclerosis	4.71e-05	0.0002	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP7A1—atherosclerosis	4.67e-05	0.000198	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NOS3—atherosclerosis	4.5e-05	0.000191	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	4.45e-05	0.000189	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CXCL8—atherosclerosis	4.33e-05	0.000184	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CYP27A1—atherosclerosis	4.31e-05	0.000183	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	4.25e-05	0.00018	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—AKT1—atherosclerosis	4.19e-05	0.000178	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	4.14e-05	0.000176	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—IL6—atherosclerosis	4.12e-05	0.000175	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX15—atherosclerosis	4.09e-05	0.000173	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA2—atherosclerosis	4.09e-05	0.000173	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	4.09e-05	0.000173	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	4.09e-05	0.000173	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCG5—atherosclerosis	4.04e-05	0.000171	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	4.03e-05	0.000171	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CXCL8—atherosclerosis	3.99e-05	0.000169	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—atherosclerosis	3.92e-05	0.000166	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPA—atherosclerosis	3.9e-05	0.000165	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—NFKB1—atherosclerosis	3.88e-05	0.000165	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—AKT1—atherosclerosis	3.85e-05	0.000164	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK8—atherosclerosis	3.81e-05	0.000162	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—AKT1—atherosclerosis	3.8e-05	0.000161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—IL6—atherosclerosis	3.79e-05	0.000161	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—BGN—atherosclerosis	3.78e-05	0.00016	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	3.75e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA5—atherosclerosis	3.74e-05	0.000159	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	3.63e-05	0.000154	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—atherosclerosis	3.61e-05	0.000153	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	3.6e-05	0.000153	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—NFKB1—atherosclerosis	3.57e-05	0.000151	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	3.56e-05	0.000151	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	3.53e-05	0.00015	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—atherosclerosis	3.52e-05	0.000149	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	3.52e-05	0.000149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK8—atherosclerosis	3.51e-05	0.000149	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—AKT1—atherosclerosis	3.5e-05	0.000148	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—AKT1—atherosclerosis	3.49e-05	0.000148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—STAT3—atherosclerosis	3.49e-05	0.000148	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALOX5—atherosclerosis	3.48e-05	0.000148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MAPK3—atherosclerosis	3.33e-05	0.000141	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—atherosclerosis	3.24e-05	0.000137	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TGFB1—atherosclerosis	3.23e-05	0.000137	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	3.21e-05	0.000136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—STAT3—atherosclerosis	3.21e-05	0.000136	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NAMPT—atherosclerosis	3.12e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	3.1e-05	0.000132	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LIPC—atherosclerosis	3.1e-05	0.000131	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOC3—atherosclerosis	3.08e-05	0.000131	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MAPK3—atherosclerosis	3.06e-05	0.00013	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LDLR—atherosclerosis	3.06e-05	0.00013	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CETP—atherosclerosis	2.99e-05	0.000127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TGFB1—atherosclerosis	2.97e-05	0.000126	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SCARB1—atherosclerosis	2.86e-05	0.000121	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	2.79e-05	0.000118	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—AKT1—atherosclerosis	2.71e-05	0.000115	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMGCR—atherosclerosis	2.7e-05	0.000115	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	2.44e-05	0.000103	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IL6—atherosclerosis	2.43e-05	0.000103	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ABCA1—atherosclerosis	2.41e-05	0.000102	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—AKT1—atherosclerosis	2.25e-05	9.53e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IL6—atherosclerosis	2.24e-05	9.51e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—HMOX1—atherosclerosis	2.07e-05	8.77e-05	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—AKT1—atherosclerosis	2.07e-05	8.77e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOB—atherosclerosis	1.98e-05	8.4e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.93e-05	8.17e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—LPL—atherosclerosis	1.89e-05	8.02e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GPX1—atherosclerosis	1.84e-05	7.83e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CD36—atherosclerosis	1.8e-05	7.62e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—MTHFR—atherosclerosis	1.7e-05	7.22e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARA—atherosclerosis	1.67e-05	7.09e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AGT—atherosclerosis	1.62e-05	6.86e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—atherosclerosis	1.58e-05	6.72e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CAV1—atherosclerosis	1.57e-05	6.66e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOA1—atherosclerosis	1.57e-05	6.65e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PIK3CG—atherosclerosis	1.43e-05	6.07e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PPARG—atherosclerosis	1.38e-05	5.86e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—INS—atherosclerosis	1.35e-05	5.74e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—ALB—atherosclerosis	1.24e-05	5.27e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—NOS3—atherosclerosis	1.19e-05	5.04e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—atherosclerosis	1.09e-05	4.61e-05	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—AKT1—atherosclerosis	5.46e-06	2.32e-05	CbGpPWpGaD
